{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T16:26:23Z","timestamp":1794068783523,"version":"4.8.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"8139","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2026,11,5]]},"DOI":"10.1038\/s41586-026-11055-9","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T15:03:07Z","timestamp":1789570987000},"page":"208-215","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification of broadly tumour-reactive \u03b3\u03b4 TCRs from multiple myeloma"],"prefix":"10.1038","volume":"659","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5213-6415","authenticated-orcid":false,"given":"Michael","family":"St. Paul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0253-8512","authenticated-orcid":false,"given":"Liam D.","family":"Hendrikse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan E.","family":"Snow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0039-747X","authenticated-orcid":false,"given":"Ping","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Helke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Logan K.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arwa","family":"Hilal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6765-4733","authenticated-orcid":false,"given":"Dor D.","family":"Abelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisha","family":"Ramamurthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayley","family":"Nault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen N.","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Gold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Tobin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott C.","family":"Lien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dat","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwatobi","family":"Agbede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna","family":"Eagles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Wakeham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1177-0225","authenticated-orcid":false,"given":"Dalam","family":"Ly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia Bonolo","family":"de Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8668-0873","authenticated-orcid":false,"given":"Chunxing","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wesley V.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Masih-Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darrell","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arleigh","family":"McCurdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha L.","family":"Louzada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rami","family":"Kotb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Parkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Reece","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3922-3215","authenticated-orcid":false,"given":"Engin","family":"Gul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1743-8810","authenticated-orcid":false,"given":"Rodger","family":"Tiedemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor J.","family":"Pugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9070-4754","authenticated-orcid":false,"given":"Naoto","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela S.","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Keith","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7952-6352","authenticated-orcid":false,"given":"Suzanne","family":"Trudel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6766-861X","authenticated-orcid":false,"given":"Tak W.","family":"Mak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"11055_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45449-y","volume":"15","author":"SC Lien","year":"2024","unstructured":"Lien, S. C. et al. Tumor reactive \u03b3\u03b4 T cells contribute to a complete response to PD-1 blockade in a Merkel cell carcinoma patient. Nat. Commun. 15, 1094 https:\/\/doi.org\/10.1038\/s41467-024-45449-y (2024).","journal-title":"Nat. Commun."},{"key":"11055_CR2","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/s41586-022-05593-1","volume":"613","author":"NL de Vries","year":"2023","unstructured":"de Vries, N. L. et al. \u03b3\u03b4 T cells are effectors of immunotherapy in cancers with HLA class I defects. Nature 613, 743\u2013750 https:\/\/doi.org\/10.1038\/s41586-022-05593-1 (2023).","journal-title":"Nature"},{"key":"11055_CR3","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/s41590-023-01448-7","volume":"24","author":"C Rancan","year":"2023","unstructured":"Rancan, C. et al. Exhausted intratumoral V\u03b42\u2013 \u03b3\u03b4 T cells in human kidney cancer retain effector function. Nat. Immunol. 24, 612\u2013624 https:\/\/doi.org\/10.1038\/s41590-023-01448-7 (2023).","journal-title":"Nat. Immunol."},{"key":"11055_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2013.34","volume":"3","author":"C Bryant","year":"2013","unstructured":"Bryant, C. et al. Long-term survival in multiple myeloma is associated with a distinct immunological profile, which includes proliferative cytotoxic T-cell clones and a favourable Treg\/Th17 balance. Blood Cancer J. 3, e148 https:\/\/doi.org\/10.1038\/bcj.2013.34 (2013).","journal-title":"Blood Cancer J."},{"key":"11055_CR5","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.tcb.2020.06.003","volume":"30","author":"M St Paul","year":"2020","unstructured":"St Paul, M. & Ohashi, P. S. The roles of CD8+ T cell subsets in antitumor immunity. Trends Cell Biol. 30, 695\u2013704 https:\/\/doi.org\/10.1016\/j.tcb.2020.06.003 (2020).","journal-title":"Trends Cell Biol."},{"key":"11055_CR6","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1182\/bloodadvances.2017005447","volume":"1","author":"CM Ho","year":"2017","unstructured":"Ho, C. M. et al. Immune signatures associated with improved progression-free and overall survival for myeloma patients treated with AHSCT. Blood Adv. 1, 1056\u20131066 https:\/\/doi.org\/10.1182\/bloodadvances.2017005447 (2017).","journal-title":"Blood Adv."},{"key":"11055_CR7","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1126\/science.1063916","volume":"294","author":"M Girardi","year":"2001","unstructured":"Girardi, M. et al. Regulation of cutaneous malignancy by \u03b3\u03b4 T cells. Science 294, 605\u2013609 https:\/\/doi.org\/10.1126\/science.1063916 (2001).","journal-title":"Science"},{"key":"11055_CR8","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.1365-2141.2007.06754.x","volume":"139","author":"M Burjanadze","year":"2007","unstructured":"Burjanadze, M. et al. In vitro expansion of \u03b3\u03b4 T cells with anti-myeloma cell activity by phosphostim and IL-2 in patients with multiple myeloma. Br. J. Haematol. 139, 206\u2013216 https:\/\/doi.org\/10.1111\/j.1365-2141.2007.06754.x (2007).","journal-title":"Br. J. Haematol."},{"key":"11055_CR9","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.3109\/14653249.2012.700766","volume":"14","author":"A Knight","year":"2012","unstructured":"Knight, A., Mackinnon, S. & Lowdell, M. W. Human V\u03b41 \u03b3\u03b4 T cells exert potent specific cytotoxicity against primary multiple myeloma cells. Cytotherapy 14, 1110\u20131118 https:\/\/doi.org\/10.3109\/14653249.2012.700766 (2012).","journal-title":"Cytotherapy"},{"key":"11055_CR10","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/s41571-022-00722-1","volume":"20","author":"S Mensurado","year":"2023","unstructured":"Mensurado, S., Blanco-Dominguez, R. & Silva-Santos, B. The emerging roles of \u03b3\u03b4 T cells in cancer immunotherapy. Nat. Rev. Clin. Oncol. 20, 178\u2013191 https:\/\/doi.org\/10.1038\/s41571-022-00722-1 (2023).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"11055_CR11","doi-asserted-by":"publisher","DOI":"10.1126\/science.abq7248","volume":"386","author":"A Hayday","year":"2024","unstructured":"Hayday, A., Dechanet-Merville, J., Rossjohn, J. & Silva-Santos, B. Cancer immunotherapy by \u03b3\u03b4 T cells. Science 386, eabq7248 https:\/\/doi.org\/10.1126\/science.abq7248 (2024).","journal-title":"Science"},{"key":"11055_CR12","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/nm.3909","volume":"21","author":"AJ Gentles","year":"2015","unstructured":"Gentles, A. J. et al. The prognostic landscape of genes and infiltrating immune cells across human cancers. Nat. Med. 21, 938\u2013945 https:\/\/doi.org\/10.1038\/nm.3909 (2015).","journal-title":"Nat. Med."},{"key":"11055_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14760","volume":"8","author":"MS Davey","year":"2017","unstructured":"Davey, M. S. et al. Clonal selection in the human V\u03b41 T cell repertoire indicates \u03b3\u03b4 TCR-dependent adaptive immune surveillance. Nat. Commun. 8, 14760 https:\/\/doi.org\/10.1038\/ncomms14760 (2017).","journal-title":"Nat. Commun."},{"key":"11055_CR14","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.cell.2016.08.030","volume":"167","author":"R Di Marco Barros","year":"2016","unstructured":"Di Marco Barros, R. et al. Epithelia use butyrophilin-like molecules to shape organ-specific \u03b3\u03b4 T cell compartments. Cell 167, 203\u2013218 https:\/\/doi.org\/10.1016\/j.cell.2016.08.030 (2016).","journal-title":"Cell"},{"key":"11055_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110858","volume":"39","author":"JL McMurray","year":"2022","unstructured":"McMurray, J. L. et al. Transcriptional profiling of human V\u03b41 T cells reveals a pathogen-driven adaptive differentiation program. Cell Rep. 39, 110858 https:\/\/doi.org\/10.1016\/j.celrep.2022.110858 (2022).","journal-title":"Cell Rep."},{"key":"11055_CR16","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/ni.3686","volume":"18","author":"S Ravens","year":"2017","unstructured":"Ravens, S. et al. Human \u03b3\u03b4 T cells are quickly reconstituted after stem-cell transplantation and show adaptive clonal expansion in response to viral infection. Nat. Immunol. 18, 393\u2013401 https:\/\/doi.org\/10.1038\/ni.3686 (2017).","journal-title":"Nat. Immunol."},{"key":"11055_CR17","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1182\/blood-2011-02-339135","volume":"118","author":"DV Correia","year":"2011","unstructured":"Correia, D. V. et al. Differentiation of human peripheral blood V\u03b41+ T cells expressing the natural cytotoxicity receptor NKp30 for recognition of lymphoid leukemia cells. Blood 118, 992\u20131001 https:\/\/doi.org\/10.1182\/blood-2011-02-339135 (2011).","journal-title":"Blood"},{"key":"11055_CR18","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aax9364","volume":"11","author":"Y Wu","year":"2019","unstructured":"Wu, Y. et al. An innate-like V\u03b41+ \u03b3\u03b4 T cell compartment in the human breast is associated with remission in triple-negative breast cancer. Sci. Transl. Med. 11, eaax9364 https:\/\/doi.org\/10.1126\/scitranslmed.aax9364 (2019).","journal-title":"Sci. Transl. Med."},{"key":"11055_CR19","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41590-018-0304-y","volume":"20","author":"BE Willcox","year":"2019","unstructured":"Willcox, B. E. & Willcox, C. R. \u03b3\u03b4 TCR ligands: the quest to solve a 500-million-year-old mystery. Nat. Immunol. 20, 121\u2013128 https:\/\/doi.org\/10.1038\/s41590-018-0304-y (2019).","journal-title":"Nat. Immunol."},{"key":"11055_CR20","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1056\/NEJMoa2405090","volume":"391","author":"V Hungria","year":"2024","unstructured":"Hungria, V. et al. Belantamab mafodotin, bortezomib, and dexamethasone for multiple myeloma. N. Engl. J. Med. 391, 393\u2013407 https:\/\/doi.org\/10.1056\/NEJMoa2405090 (2024).","journal-title":"N. Engl. J. Med."},{"key":"11055_CR21","doi-asserted-by":"publisher","first-page":"3746","DOI":"10.1002\/cncr.34987","volume":"129","author":"AK Nooka","year":"2023","unstructured":"Nooka, A. K. et al. Single-agent belantamab mafodotin in patients with relapsed\/refractory multiple myeloma: final analysis of the DREAMM-2 trial. Cancer 129, 3746\u20133760 https:\/\/doi.org\/10.1002\/cncr.34987 (2023).","journal-title":"Cancer"},{"key":"11055_CR22","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/s41591-023-02703-y","volume":"30","author":"S Trudel","year":"2024","unstructured":"Trudel, S. et al. Belantamab mafodotin, pomalidomide and dexamethasone in refractory multiple myeloma: a phase 1\/2 trial. Nat. Med. 30, 543\u2013551 https:\/\/doi.org\/10.1038\/s41591-023-02703-y (2024).","journal-title":"Nat. Med."},{"key":"11055_CR23","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2147\/BLCTT.S490021","volume":"14","author":"AA Almodovar Diaz","year":"2024","unstructured":"Almodovar Diaz, A. A., Alouch, S. S., Chawla, Y. & Gonsalves, W. I. The antibody drug conjugate, belantamab\u2013mafodotin, in the treatment of multiple myeloma: a comprehensive review. Blood Lymphat. Cancer 14, 71\u201387 https:\/\/doi.org\/10.2147\/BLCTT.S490021 (2024).","journal-title":"Blood Lymphat. Cancer"},{"key":"11055_CR24","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1158\/1535-7163.MCT-21-0035","volume":"20","author":"R Montes de Oca","year":"2021","unstructured":"Montes de Oca, R. et al. Belantamab mafodotin (GSK2857916) drives immunogenic cell death and immune-mediated antitumor responses in vivo. Mol. Cancer Ther. 20, 1941\u20131955 https:\/\/doi.org\/10.1158\/1535-7163.MCT-21-0035 (2021).","journal-title":"Mol. Cancer Ther."},{"key":"11055_CR25","doi-asserted-by":"publisher","first-page":"e801","DOI":"10.1016\/S2352-3026(23)00243-0","volume":"10","author":"MA Dimopoulos","year":"2023","unstructured":"Dimopoulos, M. A. et al. Efficacy and safety of single-agent belantamab mafodotin versus pomalidomide plus low-dose dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-3): a phase 3, open-label, randomised study. Lancet Haematol. 10, e801\u2013e812 https:\/\/doi.org\/10.1016\/S2352-3026(23)00243-0 (2023).","journal-title":"Lancet Haematol."},{"key":"11055_CR26","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1056\/NEJMoa2403407","volume":"391","author":"MA Dimopoulos","year":"2024","unstructured":"Dimopoulos, M. A. et al. Belantamab mafodotin, pomalidomide, and dexamethasone in multiple myeloma. N. Engl. J. Med. 391, 408\u2013421 https:\/\/doi.org\/10.1056\/NEJMoa2403407 (2024).","journal-title":"N. Engl. J. Med."},{"key":"11055_CR27","doi-asserted-by":"publisher","first-page":"3506","DOI":"10.1182\/bloodadvances.2017014639","volume":"2","author":"DT Mulder","year":"2018","unstructured":"Mulder, D. T. et al. CapTCR-seq: hybrid capture for T-cell receptor repertoire profiling. Blood Adv. 2, 3506\u20133514 https:\/\/doi.org\/10.1182\/bloodadvances.2017014639 (2018).","journal-title":"Blood Adv."},{"key":"11055_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.116190","volume":"44","author":"S Soleimani","year":"2025","unstructured":"Soleimani, S. et al. T cell receptor repertoire in cell-free DNA as a proxy for tumor infiltrates in patients treated with pembrolizumab. Cell Rep. 44, 116190 https:\/\/doi.org\/10.1016\/j.celrep.2025.116190 (2025).","journal-title":"Cell Rep."},{"key":"11055_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/mtm.2015.54","volume":"3","author":"XZ Guo","year":"2016","unstructured":"Guo, X. Z. et al. Rapid cloning, expression, and functional characterization of paired \u03b1\u03b2 and \u03b3\u03b4 T-cell receptor chains from single-cell analysis. Mol. Ther. Methods Clin. Dev. 3, 15054 https:\/\/doi.org\/10.1038\/mtm.2015.54 (2016).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"11055_CR30","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1126\/science.abl5447","volume":"375","author":"FJ Lowery","year":"2022","unstructured":"Lowery, F. J. et al. Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancers. Science 375, 877\u2013884 https:\/\/doi.org\/10.1126\/science.abl5447 (2022).","journal-title":"Science"},{"key":"11055_CR31","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adh9562","volume":"15","author":"Z Meng","year":"2023","unstructured":"Meng, Z. et al. Transcriptome-based identification of tumor-reactive and bystander CD8+ T cell receptor clonotypes in human pancreatic cancer. Sci. Transl. Med. 15, eadh9562 https:\/\/doi.org\/10.1126\/scitranslmed.adh9562 (2023).","journal-title":"Sci. Transl. Med."},{"key":"11055_CR32","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1016\/j.ccell.2023.11.005","volume":"41","author":"R Yossef","year":"2023","unstructured":"Yossef, R. et al. Phenotypic signatures of circulating neoantigen-reactive CD8+ T cells in patients with metastatic cancers. Cancer Cell 41, 2154\u20132165 https:\/\/doi.org\/10.1016\/j.ccell.2023.11.005 (2023).","journal-title":"Cancer Cell"},{"key":"11055_CR33","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.ccell.2022.03.012","volume":"40","author":"KI Hanada","year":"2022","unstructured":"Hanada, K. I. et al. A phenotypic signature that identifies neoantigen-reactive T cells in fresh human lung cancers. Cancer Cell 40, 479\u2013493 https:\/\/doi.org\/10.1016\/j.ccell.2022.03.012 (2022).","journal-title":"Cancer Cell"},{"key":"11055_CR34","doi-asserted-by":"publisher","unstructured":"Petremand, R. et al. Identification of clinically relevant T cell receptors for personalized T cell therapy using combinatorial algorithms. Nat. Biotechnol. 43, 323\u2013328 https:\/\/doi.org\/10.1038\/s41587-024-02232-0 (2025).","DOI":"10.1038\/s41587-024-02232-0"},{"key":"11055_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101764","volume":"5","author":"X Yu","year":"2024","unstructured":"Yu, X. et al. Pan-cancer \u03b3\u03b4 TCR analysis uncovers clonotype diversity and prognostic potential. Cell Rep. Med. 5, 101764 https:\/\/doi.org\/10.1016\/j.xcrm.2024.101764 (2024).","journal-title":"Cell Rep. Med."},{"key":"11055_CR36","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1158\/2159-8290.CD-23-0798","volume":"14","author":"ZZ Reinstein","year":"2024","unstructured":"Reinstein, Z. Z. et al. Preexisting skin-resident CD8 and \u03b3\u03b4 T-cell circuits mediate immune response in merkel cell carcinoma and predict immunotherapy efficacy. Cancer Discov. 14, 1631\u20131652 https:\/\/doi.org\/10.1158\/2159-8290.CD-23-0798 (2024).","journal-title":"Cancer Discov."},{"key":"11055_CR37","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1182\/blood-2006-11-056168","volume":"110","author":"M Wolfl","year":"2007","unstructured":"Wolfl, M. et al. Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T cells responding to antigen without requiring knowledge of epitope specificities. Blood 110, 201\u2013210 https:\/\/doi.org\/10.1182\/blood-2006-11-056168 (2007).","journal-title":"Blood"},{"key":"11055_CR38","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-006264","volume":"11","author":"PD Chatani","year":"2023","unstructured":"Chatani, P. D. et al. Cell surface marker-based capture of neoantigen-reactive CD8+ T-cell receptors from metastatic tumor digests. J. Immunother. Cancer 11, e006264 https:\/\/doi.org\/10.1136\/jitc-2022-006264 (2023).","journal-title":"J. Immunother. Cancer"},{"key":"11055_CR39","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41586-021-03752-4","volume":"596","author":"JX Caushi","year":"2021","unstructured":"Caushi, J. X. et al. Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers. Nature 596, 126\u2013132 https:\/\/doi.org\/10.1038\/s41586-021-03752-4 (2021).","journal-title":"Nature"},{"key":"11055_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-55059-3","volume":"16","author":"Z Zeng","year":"2025","unstructured":"Zeng, Z. et al. A minimal gene set characterizes TIL specific for diverse tumor antigens across different cancer types. Nat. Commun. 16, 1070 https:\/\/doi.org\/10.1038\/s41467-024-55059-3 (2025).","journal-title":"Nat. Commun."},{"key":"11055_CR41","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cellimm.2015.02.010","volume":"296","author":"CD Pauza","year":"2015","unstructured":"Pauza, C. D. & Cairo, C. Evolution and function of the TCR V\u03b39 chain repertoire: it\u2019s good to be public. Cell Immunol. 296, 22\u201330 https:\/\/doi.org\/10.1016\/j.cellimm.2015.02.010 (2015).","journal-title":"Cell Immunol."},{"key":"11055_CR42","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41392-023-01653-8","volume":"8","author":"Y Hu","year":"2023","unstructured":"Hu, Y. et al. \u03b3\u03b4 T cells: origin and fate, subsets, diseases and immunotherapy. Signal Transduct. Target. Ther. 8, 434 https:\/\/doi.org\/10.1038\/s41392-023-01653-8 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"11055_CR43","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.53244","volume":"9","author":"K Murata","year":"2020","unstructured":"Murata, K. et al. Landscape mapping of shared antigenic epitopes and their cognate TCRs of tumor-infiltrating T lymphocytes in melanoma. eLife 9, e53244 https:\/\/doi.org\/10.7554\/eLife.53244 (2020).","journal-title":"eLife"},{"key":"11055_CR44","doi-asserted-by":"publisher","first-page":"5237","DOI":"10.4049\/jimmunol.158.11.5237","volume":"158","author":"JE Gumperz","year":"1997","unstructured":"Gumperz, J. E. et al. Conserved and variable residues within the Bw4 motif of HLA-B make separable contributions to recognition by the NKB1 killer cell-inhibitory receptor. J. Immunol. 158, 5237\u20135241 (1997).","journal-title":"J. Immunol."},{"key":"11055_CR45","doi-asserted-by":"publisher","first-page":"17951","DOI":"10.1073\/pnas.1905943116","volume":"116","author":"J Geng","year":"2019","unstructured":"Geng, J. & Raghavan, M. CD8\u03b1\u03b1 homodimers function as a coreceptor for KIR3DL1. Proc. Natl Acad. Sci. USA 116, 17951\u201317956 https:\/\/doi.org\/10.1073\/pnas.1905943116 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"11055_CR46","doi-asserted-by":"publisher","first-page":"5795","DOI":"10.1158\/1078-0432.CCR-16-0597","volume":"22","author":"AR Almeida","year":"2016","unstructured":"Almeida, A. R. et al. Delta one T cells for immunotherapy of chronic lymphocytic leukemia: clinical-grade expansion\/differentiation and preclinical proof of concept. Clin. Cancer Res. 22, 5795\u20135804 https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-0597 (2016).","journal-title":"Clin. Cancer Res."},{"key":"11055_CR47","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.125884","volume":"4","author":"J Mikulak","year":"2019","unstructured":"Mikulak, J. et al. NKp46-expressing human gut-resident intraepithelial V\u03b41 T cell subpopulation exhibits high antitumor activity against colorectal cancer. JCI Insight 4, e125884 https:\/\/doi.org\/10.1172\/jci.insight.125884 (2019).","journal-title":"JCI Insight"},{"key":"11055_CR48","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/s43018-023-00690-0","volume":"5","author":"D Davies","year":"2024","unstructured":"Davies, D. et al. PD-1 defines a distinct, functional, tissue-adapted state in V\u03b41+ T cells with implications for cancer immunotherapy. Nat. Cancer 5, 420\u2013432 https:\/\/doi.org\/10.1038\/s43018-023-00690-0 (2024).","journal-title":"Nat. Cancer"},{"key":"11055_CR49","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s43018-022-00376-z","volume":"3","author":"Y Wu","year":"2022","unstructured":"Wu, Y. et al. A local human V\u03b41 T cell population is associated with survival in nonsmall-cell lung cancer. Nat. Cancer 3, 696\u2013709 https:\/\/doi.org\/10.1038\/s43018-022-00376-z (2022).","journal-title":"Nat. Cancer"},{"key":"11055_CR50","doi-asserted-by":"publisher","DOI":"10.1172\/JCI172156","volume":"133","author":"HL Chang","year":"2023","unstructured":"Chang, H. L., Schwettmann, B., McArthur, H. L. & Chan, I. S. Antibody\u2013drug conjugates in breast cancer: overcoming resistance and boosting immune response. J. Clin. Invest. 133, e172156 https:\/\/doi.org\/10.1172\/JCI172156 (2023).","journal-title":"J. Clin. Invest."},{"key":"11055_CR51","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2509016122","volume":"122","author":"KS Kao","year":"2025","unstructured":"Kao, K. S. et al. Fc\u03b3RIIIa is a noncanonical costimulatory molecule for CD8 T cells. Proc. Natl Acad. Sci. USA 122, e2509016122 https:\/\/doi.org\/10.1073\/pnas.2509016122 (2025).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"11055_CR52","doi-asserted-by":"publisher","first-page":"3530","DOI":"10.1182\/blood-2003-05-1524","volume":"102","author":"MH Heemskerk","year":"2003","unstructured":"Heemskerk, M. H. et al. Redirection of antileukemic reactivity of peripheral T lymphocytes using gene transfer of minor histocompatibility antigen HA-2-specific T-cell receptor complexes expressing a conserved alpha joining region. Blood 102 3530\u20133540 https:\/\/doi.org\/10.1182\/blood-2003-05-1524 (2003).","journal-title":"Blood"},{"key":"11055_CR53","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/s0092-8674(00)80436-5","volume":"91","author":"Z Ivics","year":"1997","unstructured":"Ivics, Z., Hackett, P. B., Plasterk, R. H. & Izsvak, Z. Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells. Cell 91, 501\u2013510 https:\/\/doi.org\/10.1016\/s0092-8674(00)80436-5 (1997).","journal-title":"Cell"},{"key":"11055_CR54","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/gt.2011.40","volume":"18","author":"Z Jin","year":"2011","unstructured":"Jin, Z. et al. The hyperactive Sleeping Beauty transposase SB100X improves the genetic modification of T cells to express a chimeric antigen receptor. Gene Ther. 18, 849\u2013856 https:\/\/doi.org\/10.1038\/gt.2011.40 (2011).","journal-title":"Gene Ther."},{"key":"11055_CR55","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.63972","volume":"10","author":"AR Strom","year":"2021","unstructured":"Strom, A. R. et al. HP1\u03b1 is a chromatin crosslinker that controls nuclear and mitotic chromosome mechanics. eLife 10, e63972 https:\/\/doi.org\/10.7554\/eLife.63972 (2021).","journal-title":"eLife"},{"key":"11055_CR56","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ymeth.2017.10.008","volume":"133","author":"S Oh","year":"2018","unstructured":"Oh, S. & Kessler, J. A. Design, assembly, production, and transfection of synthetic modified mRNA. Methods 133, 29\u201343 https:\/\/doi.org\/10.1016\/j.ymeth.2017.10.008 (2018).","journal-title":"Methods"},{"key":"11055_CR57","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.stem.2010.08.012","volume":"7","author":"L Warren","year":"2010","unstructured":"Warren, L. et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7, 618\u2013630 https:\/\/doi.org\/10.1016\/j.stem.2010.08.012 (2010).","journal-title":"Cell Stem Cell"},{"key":"11055_CR58","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1101\/gad.5.11.2108","volume":"5","author":"DR Gallie","year":"1991","unstructured":"Gallie, D. R. The cap and poly(A) tail function synergistically to regulate mRNA translational efficiency. Genes Dev. 5, 2108\u20132116 https:\/\/doi.org\/10.1101\/gad.5.11.2108 (1991).","journal-title":"Genes Dev."},{"key":"11055_CR59","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1084\/jem.191.6.937","volume":"191","author":"FM Spada","year":"2000","unstructured":"Spada, F. M. et al. Self-recognition of CD1 by \u03b3\u03b4 T cells: implications for innate immunity. J. Exp. Med. 191, 937\u2013948 https:\/\/doi.org\/10.1084\/jem.191.6.937 (2000).","journal-title":"J. Exp. Med."},{"key":"11055_CR60","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1038\/ni.2713","volume":"14","author":"AP Uldrich","year":"2013","unstructured":"Uldrich, A. P. et al. CD1d\u2013lipid antigen recognition by the \u03b3\u03b4 TCR. Nat. Immunol. 14, 1137\u20131145 https:\/\/doi.org\/10.1038\/ni.2713 (2013).","journal-title":"Nat. Immunol."},{"key":"11055_CR61","doi-asserted-by":"publisher","first-page":"e30229","DOI":"10.1371\/journal.pone.0030229","volume":"7","author":"MO Butler","year":"2012","unstructured":"Butler, M. O. et al. Ex vivo expansion of human CD8+ T cells using autologous CD4+ T cell help. PLoS ONE 7, e30229 https:\/\/doi.org\/10.1371\/journal.pone.0030229 (2012).","journal-title":"PLoS ONE"},{"key":"11055_CR62","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/s41592-019-0392-0","volume":"16","author":"EP Mimitou","year":"2019","unstructured":"Mimitou, E. P. et al. Multiplexed detection of proteins, transcriptomes, clonotypes and CRISPR perturbations in single cells. Nat. Methods 16, 409\u2013412 https:\/\/doi.org\/10.1038\/s41592-019-0392-0 (2019).","journal-title":"Nat. Methods"},{"key":"11055_CR63","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1158\/2326-6066.CIR-20-0817","volume":"9","author":"NA Gherardin","year":"2021","unstructured":"Gherardin, N. A. et al. \u03b3\u03b4 T cells in Merkel cell carcinomas have a proinflammatory profile prognostic of patient survival. Cancer Immunol. Res. 9, 612\u2013623 https:\/\/doi.org\/10.1158\/2326-6066.CIR-20-0817 (2021).","journal-title":"Cancer Immunol. Res."},{"key":"11055_CR64","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573\u20133587 https:\/\/doi.org\/10.1016\/j.cell.2021.04.048 (2021).","journal-title":"Cell"},{"key":"11055_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1874-1","volume":"20","author":"C Hafemeister","year":"2019","unstructured":"Hafemeister, C. & Satija, R. Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression. Genome Biol. 20, 296 https:\/\/doi.org\/10.1186\/s13059-019-1874-1 (2019).","journal-title":"Genome Biol."},{"key":"11055_CR66","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289\u20131296 https:\/\/doi.org\/10.1038\/s41592-019-0619-0 (2019).","journal-title":"Nat. Methods"},{"key":"11055_CR67","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1111\/j.1654-1103.2003.tb02228.x","volume":"14","author":"P Dixon","year":"2003","unstructured":"Dixon, P. VEGAN, a package of R functions for community ecology. J. Veg. Sci. 14, 927\u2013930 https:\/\/doi.org\/10.1111\/j.1654-1103.2003.tb02228.x (2003).","journal-title":"J. Veg. Sci."},{"key":"11055_CR68","first-page":"1","volume":"18","author":"G Lema\u00eetre","year":"2017","unstructured":"Lema\u00eetre, G., Nogueira, F. & Aridas, C. K. Imbalanced-learn: a Python toolbox to tackle the curse of imbalanced datasets in machine learning. J. Mach. Learn. 18, 1\u20135 (2017).","journal-title":"J. Mach. Learn."},{"key":"11055_CR69","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/nmeth.3364","volume":"12","author":"DA Bolotin","year":"2015","unstructured":"Bolotin, D. A. et al. MiXCR: software for comprehensive adaptive immunity profiling. Nat. Methods 12, 380\u2013381 https:\/\/doi.org\/10.1038\/nmeth.3364 (2015).","journal-title":"Nat. Methods"},{"key":"11055_CR70","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/nbt.3979","volume":"35","author":"DA Bolotin","year":"2017","unstructured":"Bolotin, D. A. et al. Antigen receptor repertoire profiling from RNA-seq data. Nat. Biotechnol. 35, 908\u2013911 https:\/\/doi.org\/10.1038\/nbt.3979 (2017).","journal-title":"Nat. Biotechnol."},{"key":"11055_CR71","doi-asserted-by":"publisher","unstructured":"Hendrikse, L., St Paul, M. & Luo, P. Predicting tumor-reactive gamma delta TCRs (PreGame) [Computer software]. Zenodo https:\/\/doi.org\/10.5281\/zenodo.20028241 (2026).","DOI":"10.5281\/zenodo.20028241"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-11055-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-11055-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-11055-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T16:03:06Z","timestamp":1794067386000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-11055-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":71,"journal-issue":{"issue":"8139","published-print":{"date-parts":[[2026,11,5]]}},"alternative-id":["11055"],"URL":"https:\/\/doi.org\/10.1038\/s41586-026-11055-9","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]},"assertion":[{"value":"7 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.S.P., L.D.H., B.E.S., P.L. and T.W.M. have filed a provisional patent related the use of PreGame and PreGame markers to identify TR \u03b3\u03b4 T cells titled \u2018Methods of identifying tumour reactive immune cells\u2019 (US63\/895,410). T.W.M. reports consulting relationships with Treadwell Therapeutics, AstraZeneca, and Agios Pharmaceuticals. T.W.M. is a cofounder of, and holds equity in, Treadwell Therapeutics and TCRyption; however, this work was conducted independently and is unrelated to his roles in these companies. S.T. discloses consultancy (GSK), research funding (BMS, Genentech, GSK, Janssen, K36 therapeutics, Pfizer, Roche), honoraria (AstraZeneca, GSK, Janssen) and advisory committees (AstraZeneca, BMS, GSK, Janssen, Kite\/Arcellx, Pfizer, Roche, Sanofi). The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}